Skip to main content

Table 1 Patient demographics

From: Dynamics of the bacterial gut microbiota in preterm and term infants after intravenous amoxicillin/ceftazidime treatment

  

Control

ST

LT

Infants

n

28

22

13

 

Gestational age (weeks)

34.8 ± 1.4

34.2 ± 2.2

37.2 ± 3.1

 

Birthweight (gram)

2309 ± 456

2406 ± 588

3111 ± 863

 

Vaginal birth

13 (46.4%)

15 (68.2%)

6 (46.2%)

 

Male

13 (46.4%)

13 (59.1%)

8 (61.5%)

 

Preterm

24 (85.7%)

19 (86.4%)

7 (53.8%)

 

Twin

11 (39.3%)

5 (22.7%)

2 (15.4%)

 

AB treatment (days)

0

2.2 ± 0.5

7.5 ± 2.2

 

CPAP

5 (17.9%)

10 (45.5%)

0 (0%)

 

Food intolerant

0 (0%)

0 (0%)

1 (7.7%)

 

TPN

2 (7.1%)

0 (0%)

1 (7.7%)

 

Days until FEF

7.0 ± 1.0

7.2 ± 1.3

7.6 ± 0.9

 

HM > 50% throughout 6 PNW

19 (67.9%)

15 (68.2%)

7 (53.8%)

 

% HM throughout 6 PNW

68 ± 27

71 ± 34

63 ± 32

 

Cause of infection:

   

Proven sepsis

  

3 (23.1%)

Clinical sepsis

  

6 (46.2%)

Pneumonia

  

3 (23.1%)

Meningitis

  

1 (7.7%)

 

Causative pathogen:

   

Group B Streptococcus

  

4 (30.8%)

Escherichia coli

  

1 (7.7%)

Unknown

  

8 (61.5%)

Mothers

Preeclampsia

5 (17.9%)

3 (13.6%)

2 (15.4%)

 

PROM

5 (17.9%)

5 (22.7%)

6 (46.2%)

 

AB around birth

19 (67.9%)

15 (68.2%)

9 (69.2%)

 

AB > 48 h after birth

2 (7.1%)

3 (13.6%)

4 (30.8%)

  1. Abbreviations: AB: antibiotics, CPAP: continuous positive airway pressure, TPN: total parenteral nutrition, FEF: full enteral feeding, HM: human milk, PNW: postnatal week, PROM: prolonged rupture of membranes